Patents by Inventor Shinji OKI

Shinji OKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic Agent for Progressive Disease Caused by Increase in Eomes-Positive CD4-Positive T Cells
    Publication number: 20230405033
    Abstract: The present invention provides a therapeutic agent for progressive disease caused by an increase in Eomes-positive CD4-positive T cells, comprising a compound represented by formula (I) or a salt thereof as an active ingredient. In the formula, R1 is an aldopyranose residue, R2 is a hydrogen atom or a hydroxy group, R3 is —CH2—, —CH(OH)—CH2—, or —CH?CH—, R4 is a hydrogen atom or CH3, x is 0 to 35, and y and z each are an integer satisfying y+z=0 to 3.
    Type: Application
    Filed: November 6, 2020
    Publication date: December 21, 2023
    Applicant: National Center of Neurology and Psychiatry
    Inventors: Takashi Yamaura, Shinji Oki, Benjamin Joseph Edward Raveney, Wakiro Sato, Tomoko Okamoto
  • PROPHYLACTIC AGENT, ONSET-SUPPRESSING AGENT OR THERAPEUTIC AGENT FOR PROGRESSIVE IMMUNE DEMYELINATING DISEASES
    Publication number: 20210230282
    Abstract: The present invention provides a prophylactic agent, onset-suppressing agent, or therapeutic agent for progressive immune demyelinating diseases comprising, as an active ingredient, a substance capable of suppressing or inhibiting production of prolactin.
    Type: Application
    Filed: January 14, 2021
    Publication date: July 29, 2021
    Inventors: Shinji OKI, Takashi YAMAMURA
  • PROPHYLACTIC AGENT, ONSET-SUPPRESSING AGENT OR THERAPEUTIC AGENT FOR PROGRESSIVE IMMUNE DEMYELINATING DISEASES
    Publication number: 20200071408
    Abstract: The present invention provides a prophylactic agent, onset-suppressing agent, or therapeutic agent for progressive immune demyelinating diseases comprising, as an active ingredient, a substance capable of suppressing or inhibiting production of prolactin.
    Type: Application
    Filed: November 28, 2017
    Publication date: March 5, 2020
    Inventors: Shinji OKI, Takashi YAMAMURA